... ii) Consumer Products Services Technology (three acquisitions) › Completion of the EUR 200 ... The program was executed in two steps (phase one through the Wendel Group market placement and phase ...
01Net
-
25-7-2024
|
|
|
|
BGM0504 is a dual GIP/GLP - 1 receptor agonist for treating type 2 diabetes, obesity, and NASH, currently in the late stages of Phase II clinical trials. Reference Yuan, J., Liu, W., Jiang, X. et al. ...
Adnkronos
-
22-7-2024
|
|
|
|
The company will seek Contract Research Organization (CRO) pitches for a Phase II clinical trial in Q4 2024. SIFI will focus its clinical development program on two major geographies, such as the USA ...
Adnkronos
-
22-7-2024
|
|
|
|
... Sable 1999 Compra ora 14% Panasonic LUMIX DC - S5 II, Corpo Macchina Mirrorless Full Frame con ... Registrazione 4K 60P e 6K 30P Illimitata, Flip Screen, Wi - Fi, Phase Hybrid AF, Batteria DMW - ...
Hardware Upgrade
-
16-7-2024
|
|
|
SAN FRANCISCO-(BUSINESS WIRE)-TurbineOne announces it has been selected by AFWERX for a Direct - to - Phase II contract in the amount of over $1 million focused on sharing ML models at the edge within autonomous drone swarms using TurbineOne's Frontline Perception System (FPS) software, to address the ...
01Net
-
10-7-2024
|
|
|
|
...in education and medical training will be highly valuable to us as we enter the next phase of ...M&A." Improve International will be the seventh investment of Levine Leichtman Capital Partners Europe II,...
Adnkronos
-
10-7-2024
|
|
|
... Beck Depression Inventory II (BDI II), Psychological Inflexibility in Pain Scale (PIPS), and the ... a phase 3, multicentre, randomised controlled trial' is available online at https://www.thelancet.
01Net
-
9-7-2024
|
|
|
... Clear Street's Chief Executive Officer, as they lead Clear Street through the next phase of growth. These materials are: (i) solely an overview of Clear Street's products and services; (ii) provided ...
01Net
-
8-7-2024
|
|
|
I am excited to lead Amide's next phase of growth and ensure that peptide sourcing accelerates, ... projected to reach $82.6 billion by 2032 , includes well - known drugs for conditions such as Type II ...
01Net
-
27-6-2024
|
|
|
|
|
|